Native Antigen Company

Start Date End Date Funded Value Relevance

CSV

25 50 100

£445,720

Apr 20 - Sep 21

Development of an ovine polyclonal immunoglobulin therapy against COVID-19.

COVID award to Public Health England and Stuart Dowall

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}